Upgrade for detailed insurance, legislation, and other documents analytics for individual cases; real-time analysis of the datasets from your EHR, CRM, ERP, or other software; and more Enterprise Features.
ALL MEDICAL CODES IN CATEGORY Temporary Codes Q0035-Q9992 > Anti-Inflammatory Medication and Chemotherapy Medication Q5103-Q5111
2025 HCPCS code Q5110
1 mcg of Nivestym™ (filgrastim-aafi), a granulocyte colony-stimulating factor (G-CSF), administered via subcutaneous injection or intravenous infusion to stimulate granulocyte production.
2025 HCPCS code Q5108
This HCPCS code represents 0.5 mg of pegfilgrastim-jmdb (Fulphila), a biosimilar used to reduce infection risk in patients undergoing myelosuppressive chemotherapy.
2025 HCPCS code Q5106
Injection, epoetin alfa-epbx, biosimilar, (Retacrit) (for non-ESRD use), 1000 units
2025 HCPCS code Q5104
Infliximab-abda (Renflexis), 10 mg
2025 HCPCS code Q5107
Injection, bevacizumab-awwb, biosimilar, 10 mg
2025 HCPCS code Q5103
Infliximab-dyyb injection, biosimilar to infliximab, 10 mg
2025 HCPCS code Q5105
Injection, epoetin alfa-epbx, biosimilar, (retacrit), 100 units
Continue with Personal Account
Thank you for exploring iFrame ♥ Please subscribe for unlimited access to our top-tier AI model, which directly supports our dedicated knowledge creators maintaining an ad-free internet experience.